2-[[(2R)-2-amino-4-methylpentanoyl]amino]acetic acid

We are 2-[[(2R)-2-amino-4-methylpentanoyl]amino]acetic acid CAS:997-05-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  2-[[(2R)-2-amino-4-methylpentanoyl]amino]acetic acid
CAS.NO:997-05-7
Molecular Formula:C8H16N2O3
Molecular Weight:188.22400

Synonyms:
H-D-LEU-GLY-OH
N-D-leucyl-glycine
D-leucylglycine
DLEUCYL-GLYCINE extrapure
D-Leucyl=>ycin
N-D-Leucyl-glycin
D-LEU-GLY

Physical and Chemical Properties:
Density: 1.136g / cm3
Boiling point: 410.4ºC at 760mmHg
Flash point: 202ºC
Refractive index: 1.488

Specification:
Appearance: White powder solid
Purity:≥98%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at -20ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.

Related News: Nevertheless, many other didn’t appear to need confirmation. Posts on Weibo, China’s Twitter-like platform, purportedly showed people lining up at night outside pharmacies across China to buy Shuanghuanglian.Methanesulfonamide Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.3-Chloro-1-propanol CAS:627-30-5 Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.2-cloro-5-metil-3-nitropiridina CAS:23056-40-8 The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development.